dc.contributor.author | Heatley, N | |
dc.contributor.author | Harrington, KJ | |
dc.contributor.author | Thway, K | |
dc.date.accessioned | 2017-09-25T15:29:22Z | |
dc.date.issued | 2018-02-01 | |
dc.identifier.citation | International journal of surgical pathology, 2018, 26 (1), pp. 31 - 33 | |
dc.identifier.issn | 1066-8969 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/839 | |
dc.identifier.eissn | 1940-2465 | |
dc.identifier.doi | 10.1177/1066896917724889 | |
dc.description.abstract | Mucoepidermoid carcinoma (MEC) shows a wide morphologic spectrum, including epithelium with oncocytic or squamous metaplastic changes overlying a prominent cystic architecture, as well as tumor-associated lymphoid tissue. We illustrate a case of MEC of the parotid in a 17-year-old female, in which all these features occurred extensively, such that they accounted for almost the entire neoplasm, and closely mimicked Warthin tumor histologically. This highlights the need for diagnostic awareness of this particular morphologic variant of MEC, as patients could potentially be inappropriately discharged from follow-up if diagnosed with a benign neoplasm. | |
dc.format | Print-Electronic | |
dc.format.extent | 31 - 33 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | SAGE PUBLICATIONS INC | |
dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
dc.subject | Humans | |
dc.subject | Adenolymphoma | |
dc.subject | Carcinoma, Mucoepidermoid | |
dc.subject | Parotid Neoplasms | |
dc.subject | Diagnosis, Differential | |
dc.subject | Adolescent | |
dc.subject | Female | |
dc.title | Warthin Tumor-Like Mucoepidermoid Carcinoma. | |
dc.type | Journal Article | |
rioxxterms.funder | The Institute of Cancer Research | |
rioxxterms.identifier.project | Unspecified | |
rioxxterms.versionofrecord | 10.1177/1066896917724889 | |
rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2018-02 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | International journal of surgical pathology | |
pubs.issue | 1 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 26 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Targeted Therapy | |
dc.contributor.icrauthor | Harrington, Kevin | |